🦊/Investors

Novalis BiotechFull Portfolio

20 tracked investments · listed companies and verified rows first

Trincetrincebio.comin✓ verified

Trince is a Ghent University spin-off developing photoporation technology for physical transfection of cells as an alternative to viral vectors and electroporation.

BiotechDeep TechMedical DevicesGent, BE

Philip

Co-investorsQbic Fund

Alithea Genomicsalitheagenomics.comin𝕏Mar 2026 · $8.9M

Alithea Genomics develops RNA sequencing technologies and platforms that enable pharmaceutical, agritech, cosmetics, and academic teams to generate large-scale transcriptomic datasets for compound screening, crop engineering, and ingredient development.

AgTechBiotechDeep TechHealthtechLausanne, CH

Riccardo Dainese(CCO and Co-founder)inDaniel Alpern(CSO and Co-founder)in

Co-investorsKickfund

Altavoaltavo.eu

Altavo develops non-invasive silent speech technology using RF sensing and artificial intelligence to help patients who have lost their voice regain natural-sounding speech.

AI & Machine LearningDeep TechMedical DevicesDresden, DE

Rudolf

Co-investorsOCCIDENT

C-mo Medical Solutionsc-mo.solutionsinFeb 2023

C-mo develops an automated wearable device that records and analyzes cough patterns in real-time for continuous patient monitoring.

Digital HealthHealthtechMedical DevicesCaparica, PT

Co-investorsBoehringer Ingelheim Venture FundPortugal Ventures

Carroucellcarroucell.comin

Carroucell develops microcarrier technology for cell and gene therapy applications, enabling cost-effective bioproduction and cell amplification.

BiotechDeep TechMedical DevicesGrenoble, FR

Tarek Fathallahin

Cergentiscergentis.comin

Cergentis is now part of Solvias and provides Targeted Locus Amplification (TLA) technology and genetic characterization services for advanced therapy development.

BiotechDeep TechHealthtechMedical Devices

Clouds of Care NVcloudsofcare.comin

Clouds of Care develops EEG and electrophysiology-based digital health technology and software (including FDA-cleared/CE-marked SaMD) to provide meaningful endpoints for clinical development in CNS disorders such as epilepsy and sleep disorders.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Co-investorsPMVWhite Fund

Docdoc.ai

HealthtechBoise, US

Walter De Brouwer(Executive Officer, Director)Hassinger David(Executive Officer)Ming-Wai Chung(Executive Officer)Alan Greene(Executive Officer)

Co-investorsComet LabsPantera Capital

Enzyreenzyre.comNov 2022

Enzyre develops a handheld diagnostic device that performs multiple blood coagulation assays in parallel to identify bleeding causes at the point of care.

BiotechDeep TechDigital HealthHealthtechMedical DevicesEindhoven, NL

Wim van den Broek(CEO)inWaander(CSO)

Co-investorsi&i Biotech FundOost NLTakeda Ventures

Fertigafertiga.comin

Fertiga is a biotech company that develops diagnostic tools to improve IVF success rates.

BiotechDigital HealthFemTechHealthtechMedical DevicesBrussels, BE

Prof. Dr. Johan Smitz(Co-founder & Chief Medical Officer)Ir. Elien Van Hecke(Co-founder & Chief Executive Officer)Prof. Dr. André Rosenthal(Co-founder & Board member)

Graphealgrapheal.cominFeb 2021

Grapheal develops graphene-based biosensors, including PFAST, a field-deployable device for fast, real-time detection of ultra-trace PFAS ("forever chemicals") in water.

CleantechDeep TechHardware

Co-investorsBpifranceEIC

Lizardlizard.bioin

BioLizard provides analytics and AI solutions to convert complex biomedical data into actionable insights for pharmaceutical and biotech companies across discovery and clinical development phases.

AI & Machine LearningBiotechData & InfrastructureHealthtech

Modalitymodality.ai

Modality.AI develops an AI-based multimodal assessment platform that uses app-collected data to help diagnose and monitor neurodegenerative diseases such as ALS.

AI & Machine LearningDigital HealthHealthtechMedical Devices

David Suendermann-Oeft(Co-founder & CEO)inDavid Pautler(Co-founder & CTO)in

Co-investorsCARELA Holding GmbHLair East Labs

myNEO Therapeuticsmyneotx.comin

myNEO provides AI-powered software for drug discovery and development, specifically targeting antibody, bispecific, ADC, cell therapy, vaccine, and neoantigen-based immunotherapy programs.

AI & Machine LearningBiotechHealthtechSaaS

BoardCedric BogaertinJan Van Den BergheinWim van Criekingein

Ohmxohmx.bioinOct 2014

Evanston, US

Thomas Meade(Director)CHARLES PENNINGTON(CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD OF ISSUER)

BoardBrian Dyson(Director)Barbara Beug Dyson(Director)Peter L. Dyson(Director)Scott Hall(Director)

Peggypeggy.com𝕏

Peggy is a social marketplace app for buying, selling, and discovering contemporary art, serving artists, galleries, and collectors.

ConsumerE-commerceFintechMarketplacesMedia & Entertainment

Adam Meghji(Co-Founder)inCraig Follett(Co-Founder & CEO)in

Co-investorsBackbone AngelsEntrepreneur VenturesGarage CapitalZ Venture CapitalNomad Capital

Rarity Bioscienceraritybioscience.cominJun 2024

Rarity Bioscience develops superRCA, a molecular detection technology that identifies DNA mutations with exceptional sensitivity for precision medicine applications.

BiotechDeep TechDigital HealthHealthtechMedical DevicesUppsala, SE

Lei Chen(Co-Founder & CTO)inUlf Landegren(Co-Founder & Board Member)Per Matsson(Co-Founder & Chairman of the Board)in

Co-investorsNavigare Ventures

Rheavitarheavita.comin

RheaVita manufactures scalable freeze-dryer systems for pharmaceutical and vaccine development, ranging from R&D models to GMP-compliant production units.

Advanced ManufacturingBiotechDeep TechHardwareMedical DevicesGhent, BE

Jos Corver(Co-founder)inThomas De Beer(CEO)in

Co-investorsPMV

RheumaFinderrheumafinder.aiin

RheumaFinder is an AI-powered application that analyzes CT images to detect structural bone lesions in the sacroiliac joints, intended to support radiologists in identifying patients with rheumatic disease.

AI & Machine LearningHealthtechMedical Devices

Nicolaas Fosselle(Founder)in

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

H42 Inc

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.